A novel strategy to increase the proliferative potential of adult human β-cells while maintaining their differentiated phenotype.
Our previous studies demonstrated that Wnt/GSK-3/β-catenin and mTOR signaling are necessary to stimulate proliferative processes in adult human β-cells. Direct inhibition of GSK-3, that engages Wnt signaling downstream of the Wnt receptor, increases β-catenin nuclear translocation and β-cell prolife...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3680388?pdf=render |
_version_ | 1818061121076068352 |
---|---|
author | Haytham Aly Nidhi Rohatgi Connie A Marshall Tiffani C Grossenheider Hiroyuki Miyoshi Thaddeus S Stappenbeck Scot J Matkovich Michael L McDaniel |
author_facet | Haytham Aly Nidhi Rohatgi Connie A Marshall Tiffani C Grossenheider Hiroyuki Miyoshi Thaddeus S Stappenbeck Scot J Matkovich Michael L McDaniel |
author_sort | Haytham Aly |
collection | DOAJ |
description | Our previous studies demonstrated that Wnt/GSK-3/β-catenin and mTOR signaling are necessary to stimulate proliferative processes in adult human β-cells. Direct inhibition of GSK-3, that engages Wnt signaling downstream of the Wnt receptor, increases β-catenin nuclear translocation and β-cell proliferation but results in lower insulin content. Our current goal was to engage canonical and non-canonical Wnt signaling at the receptor level to significantly increase human β-cell proliferation while maintaining a β-cell phenotype in intact islets. We adopted a system that utilized conditioned medium from L cells that expressed Wnt3a, R-spondin-3 and Noggin (L-WRN conditioned medium). In addition we used a ROCK inhibitor (Y-27632) and SB-431542 (that results in RhoA inhibition) in these cultures. Treatment of intact human islets with L-WRN conditioned medium plus inhibitors significantly increased DNA synthesis ∼6 fold in a rapamycin-sensitive manner. Moreover, this treatment strikingly increased human β-cell proliferation ∼20 fold above glucose alone. Only the combination of L-WRN conditioned medium with RhoA/ROCK inhibitors resulted in substantial proliferation. Transcriptome-wide gene expression profiling demonstrated that L-WRN medium provoked robust changes in several signaling families, including enhanced β-catenin-mediated and β-cell-specific gene expression. This treatment also increased expression of Nr4a2 and Irs2 and resulted in phosphorylation of Akt. Importantly, glucose-stimulated insulin secretion and content were not downregulated by L-WRN medium treatment. Our data demonstrate that engaging Wnt signaling at the receptor level by this method leads to necessary crosstalk between multiple signaling pathways including activation of Akt, mTOR, Wnt/β-catenin, PKA/CREB, and inhibition of RhoA/ROCK that substantially increase human β-cell proliferation while maintaining the β-cell phenotype. |
first_indexed | 2024-12-10T13:43:16Z |
format | Article |
id | doaj.art-5fd82f224eb0466dbcad8713a11f8da7 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-10T13:43:16Z |
publishDate | 2013-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-5fd82f224eb0466dbcad8713a11f8da72022-12-22T01:46:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0186e6613110.1371/journal.pone.0066131A novel strategy to increase the proliferative potential of adult human β-cells while maintaining their differentiated phenotype.Haytham AlyNidhi RohatgiConnie A MarshallTiffani C GrossenheiderHiroyuki MiyoshiThaddeus S StappenbeckScot J MatkovichMichael L McDanielOur previous studies demonstrated that Wnt/GSK-3/β-catenin and mTOR signaling are necessary to stimulate proliferative processes in adult human β-cells. Direct inhibition of GSK-3, that engages Wnt signaling downstream of the Wnt receptor, increases β-catenin nuclear translocation and β-cell proliferation but results in lower insulin content. Our current goal was to engage canonical and non-canonical Wnt signaling at the receptor level to significantly increase human β-cell proliferation while maintaining a β-cell phenotype in intact islets. We adopted a system that utilized conditioned medium from L cells that expressed Wnt3a, R-spondin-3 and Noggin (L-WRN conditioned medium). In addition we used a ROCK inhibitor (Y-27632) and SB-431542 (that results in RhoA inhibition) in these cultures. Treatment of intact human islets with L-WRN conditioned medium plus inhibitors significantly increased DNA synthesis ∼6 fold in a rapamycin-sensitive manner. Moreover, this treatment strikingly increased human β-cell proliferation ∼20 fold above glucose alone. Only the combination of L-WRN conditioned medium with RhoA/ROCK inhibitors resulted in substantial proliferation. Transcriptome-wide gene expression profiling demonstrated that L-WRN medium provoked robust changes in several signaling families, including enhanced β-catenin-mediated and β-cell-specific gene expression. This treatment also increased expression of Nr4a2 and Irs2 and resulted in phosphorylation of Akt. Importantly, glucose-stimulated insulin secretion and content were not downregulated by L-WRN medium treatment. Our data demonstrate that engaging Wnt signaling at the receptor level by this method leads to necessary crosstalk between multiple signaling pathways including activation of Akt, mTOR, Wnt/β-catenin, PKA/CREB, and inhibition of RhoA/ROCK that substantially increase human β-cell proliferation while maintaining the β-cell phenotype.http://europepmc.org/articles/PMC3680388?pdf=render |
spellingShingle | Haytham Aly Nidhi Rohatgi Connie A Marshall Tiffani C Grossenheider Hiroyuki Miyoshi Thaddeus S Stappenbeck Scot J Matkovich Michael L McDaniel A novel strategy to increase the proliferative potential of adult human β-cells while maintaining their differentiated phenotype. PLoS ONE |
title | A novel strategy to increase the proliferative potential of adult human β-cells while maintaining their differentiated phenotype. |
title_full | A novel strategy to increase the proliferative potential of adult human β-cells while maintaining their differentiated phenotype. |
title_fullStr | A novel strategy to increase the proliferative potential of adult human β-cells while maintaining their differentiated phenotype. |
title_full_unstemmed | A novel strategy to increase the proliferative potential of adult human β-cells while maintaining their differentiated phenotype. |
title_short | A novel strategy to increase the proliferative potential of adult human β-cells while maintaining their differentiated phenotype. |
title_sort | novel strategy to increase the proliferative potential of adult human β cells while maintaining their differentiated phenotype |
url | http://europepmc.org/articles/PMC3680388?pdf=render |
work_keys_str_mv | AT haythamaly anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT nidhirohatgi anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT connieamarshall anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT tiffanicgrossenheider anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT hiroyukimiyoshi anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT thaddeussstappenbeck anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT scotjmatkovich anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT michaellmcdaniel anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT haythamaly novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT nidhirohatgi novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT connieamarshall novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT tiffanicgrossenheider novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT hiroyukimiyoshi novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT thaddeussstappenbeck novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT scotjmatkovich novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT michaellmcdaniel novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype |